【Yung Shin】February 2026 Monthly Revenue NT$524 Million (YoY -16.7%)
Taiwan's major pharmaceutical manufacturer, Yung Shin (3705), announced its financial data for February 2026. The company's monthly revenue was NT$524 million, a 16.7% decrease compared to the same period last year. This decline may be related to seasonal factors in pharmaceutical sales or adjustments in national health insurance drug pricing policies, reflecting the operational challenges within the pharmaceutical industry.
📋 Article Processing Timeline
- 📰 Published: February 1, 2026 at 09:00
- 🔍 Collected: April 7, 2026 at 08:00 (1559h 0m after Published)
- 🤖 AI Analyzed: April 8, 2026 at 00:19 (16h 19m after Collected)
Company Code: 3705
Company Name: Yung Shin
Industry: Biotechnology and Medical Industry
Data Month/Year: 2026-02
Monthly Revenue: NT$523,507 thousand (NT$524 million)
Year-over-year Change for Same Month: -16.7%
Company Name: Yung Shin
Industry: Biotechnology and Medical Industry
Data Month/Year: 2026-02
Monthly Revenue: NT$523,507 thousand (NT$524 million)
Year-over-year Change for Same Month: -16.7%